Page last updated: 2024-11-08

fr 110302

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

FR 110302: structure given in first source; a potent 5-lipoxygenase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164102
SCHEMBL ID6009883
MeSH IDM0200529

Synonyms (17)

Synonym
fr 110302
2,2-dibutyl-5-(2-quinolylmethoxy)-1,2,3,4-tetrahydro-1-naphthol
119256-94-9
2,2-dibutyl-5-(quinolin-2-ylmethoxy)-3,4-dihydro-1h-naphthalen-1-ol
fr-110302
fr110302
1-naphthalenol, 2,2-dibutyl-1,2,3,4-tetrahydro-5-(2-quinolinylmethoxy)-
SCHEMBL6009883
(+)-2,2-dibutyl-5-(2-quinolylmethoxy)-1,2,3,4-tetrahydro-1naphtol
(+)-2,2-dibutyl-5-(2-quinolylmethoxy)-1,2,3,4-tetrahydro-1-naphtol
(+)-2,2-dibutyl-5-(2-quinolylmethoxy)-1,2,3,4-tetrahydro-1-naphthol
PVZFWDHLBCYJIY-UHFFFAOYSA-N ,
DTXSID50922905
2,2-dibutyl-5-[(quinolin-2-yl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-ol
(1s)-2,2-dibutyl-5-(quinolin-2-ylmethoxy)-3,4-dihydro-1h-naphthalen-1-ol
PD161054
AKOS040748381

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Airway responsiveness was determined from the dose-response curve of Rrs to acetylcholine."( A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.
Asano, M; Hiroi, J; Imai, T; Inamura, N; Inoue, H; Masunaga, T; Nakahara, K; Notsu, Y; Takishima, T; Yatabe, T, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]